智通财经7月4日电，据央视新闻报道，当地时间7月3日，美国国会众议院对总统特朗普的大规模减税及 支出法案、也就是所谓的"大而美"法案进行最终表决投票。该法案现在已获得足够赞成票，实质上得以 通过。预计接下来，该法案将送至白宫，在经过美国总统特朗普签署后正式颁布。所谓"大而美"法案， 是特朗普对他推出的一项大规模税收与支出法案的简化叫法。按提出该法案的共和党方面的说法，该法 案是对特朗普第一任期减税政策的延续和升级，也是对拜登政府"绿色新政"、福利与支出等政策的缩减 与调整。该法案计划在未来10年内减税4万亿美元，并削减至少1.5万亿美元支出。 美国会众议院表决通过"大而美"法案 ...

当地时间7月3日下午，北京时间今天(7月4日)凌晨，尽管美国民主党众议员强力阻击，但共和党掌控的 众议院还是以微弱优势表决通过了参议院版本的所谓"大而美"法案，也就是美国总统特朗普力推的大规 模税收与支出法案。接下来，这一法案将被提交特朗普签字成为法律。当地时间7月1日中午，参议院凭 借副总统万斯的"一票破局"，以51票赞成、50票反对的表决结果通过该法案。而由于参议院对众议院先 前通过的版本有较大修改，众议院必须再次通过新版本。这一法案因造成联邦援助削减、长期债务增加 和为富人和大企业减税等而备受争议，被一些人士批评"劫贫济富"、将美国进一步推上财政不可持续道 路。(CCTV国际时讯) ...

智慧监管是平台的一大亮点。浙江人力资源大市场打通市场监管、司法、社保等数据，对现有1.2万家 人力资源机构开展大数据分析，推动监管从"大水漫灌"向"精准滴灌"转变。 对求职者来说，仅需注册登录浙江人力资源大市场，填写个人基本信息，就可以纵览全省岗位需求，获 取"个性化定制"的推荐岗位。目前，平台已整合全省60家公共就业人才服务网站、419家线下人力资源 市场以及超1万家人力资源服务机构资源，并通过AI技术对简历多维分析，精准推送匹配岗位。 智能匹配的，除了岗位，还有政策待遇。求职者只要点击AI人才政策小助手，输入问题，就能立即看 到小助手对各地人才政策条目化的梳理比对和智能推荐。平台归集了24类435项服务事项，覆盖个人工 作、社保、提升、维权的职业发展全周期，以及企业招聘、培训的招人用人全流程，打造24小时不打烊 的人力资源服务新生态。 重大产业、重点行业、重大平台到底缺什么人？为了切实摸清底数，浙江人力资源大市场建设了数字经 济、地理信息、半导体及光电等多个产才协同平台，帮助分析产业人才需求。同时，每月根据全省招聘 数据生成的热门行业和职位排行榜，已成为全省规划技能培训班次的重要风向标，真正实现"产业需求 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 03, 2025 WESBANCO, INC. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) West Virginia 001-39442 55-0571723 (Commission File Number) (IRS Employer Identification No.) 1 Bank Plaza Wheeling, West Virginia 26003 (Address of Principal Execu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K WESBANCO, INC. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) West Virginia 001-39442 55-0571723 (Commission File Number) (IRS Employer Identification No.) 1 Bank Plaza Wheeling, West Virginia 26003 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: 304 234-9000 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securi ...

Core Insights - MongoDB's Atlas has become a central pillar of the company's platform strategy, with strong adoption across various industries, including notable customers like CSX and LG Uplus [1] - The company reported total revenues of $549 million in the fiscal first quarter, marking a 22% year-over-year increase, with Atlas revenues growing 26% and accounting for 72% of total revenues [2] - MongoDB anticipates continued growth from Atlas, reflected in its raised revenue guidance for fiscal 2026, projected at $2.25–$2.29 billion [3] Revenue and Customer Growth - In the fiscal first quarter, Atlas customer count reached over 55,800, up from 47,700 a year ago, indicating strong customer acquisition [2] - The Zacks Consensus Estimate for MongoDB's subscription revenues for the fiscal second quarter is $537.5 million, with an estimated customer count of approximately 55,863 for Atlas [3] Strategic Initiatives - To support future growth, MongoDB is focusing on application modernization and AI, including the acquisition of Voyage AI and plans to enhance user capabilities [4] - The company is investing in developer training, certifications, and self-serve tools to drive greater adoption of Atlas [4] Competitive Landscape - MongoDB faces increasing competition from Amazon's DynamoDB and Couchbase, both enhancing their offerings in the cloud database market [5][6] - Amazon's DynamoDB has introduced multi-region strong consistency, improving its reliability for applications [5] - Couchbase has launched a new version of its cloud database designed for AI agent workflows, supporting real-time systems [6] Stock Performance and Valuation - MongoDB shares have declined by 8.7% year-to-date, underperforming the Zacks Internet – Software industry growth of 14.3% [7] - The stock is currently trading at a forward Price/Sales ratio of 6.89X, compared to the industry's 5.74X, indicating a higher valuation [11] - The Zacks Consensus Estimate for second-quarter fiscal 2026 earnings is 64 cents per share, reflecting an 8.57% year-over-year decline [15]

来源：央视新闻 乌沙科夫还称，两国领导人今天没有就举行会晤的可能性进行讨论，双方会晤的问题仍然悬而未决。 3日稍早时，俄罗斯总统普京表示，当日其将与美国总统特朗普通电话。当天，美国总统特朗普也表 示，他将于美东时间当日上午10点（北京时间22时）与俄罗斯总统普京通话。 此前曾有媒体报道，在7月4日美国"独立日"到来之际，俄美两国总统将通电话。 泽连斯基：若要实现和平俄乌领导人直接会晤不可或缺 当地时间7月3日，乌克兰总统泽连斯基在丹麦哥本哈根举行的新闻发布会上表示，若要实现俄乌之间的 和平，乌克兰与俄罗斯领导人之间的直接会晤不可或缺。 俄美元首通话约1小时讨论中东局势、俄乌谈判等 当地时间7月3日，俄罗斯总统助理乌沙科夫表示，俄总统普京与美总统特朗普的通话结束，通话持续了 约一小时。他表示，普京与特朗普的谈话"在同一频率上"，谈话务实且具体。 乌沙科夫表示，普京在与特朗普的通话中指出，俄罗斯愿意继续与乌克兰的谈判进程。乌沙科夫还称， 特朗普在与普京的通话中提出了尽早结束对乌克兰军事行动的问题。 乌沙科夫表示，普京与特朗普今日通话中未涉及美国停止对乌武器供应这一议题。双方也没有讨论俄乌 伊斯坦布尔第三轮谈判的具 ...

Core Viewpoint - Rocket Pharmaceuticals, Inc. is facing a class action lawsuit due to allegations of providing misleading information regarding its clinical trials, particularly concerning the safety of its gene therapy product RP-A501 for Danon disease [3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Ho v. Rocket Pharmaceuticals, Inc. and covers purchasers of Rocket Pharmaceuticals securities from February 27, 2025, to May 26, 2025 [1]. - The lawsuit alleges that Rocket Pharmaceuticals and a top executive violated the Securities Exchange Act of 1934 by concealing material adverse facts about the safety and clinical trial protocol of RP-A501 [3]. - It is claimed that the company failed to disclose serious adverse events, including the death of a participant, which occurred after a protocol amendment that introduced a new immunomodulatory agent [3][4]. Group 2: Impact on Stock - Following the announcement of a clinical hold by the U.S. Food and Drug Administration on May 27, 2025, due to a serious adverse event, Rocket Pharmaceuticals' stock price experienced a decline [4]. Group 3: Legal Process - Investors who purchased Rocket Pharmaceuticals securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to act on behalf of other class members [5]. - The lead plaintiff can choose a law firm to represent the class, and participation as lead plaintiff does not affect the ability to share in any potential recovery [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years, indicating its strong track record in obtaining monetary relief for investors [6].

Core Insights - Monte Rosa Therapeutics has published significant findings in Science, revealing how its AI/ML technology expands the targetable protein space for molecular glue degraders, potentially addressing previously undruggable therapeutic targets [1][2]. Company Overview - Monte Rosa Therapeutics is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader (MGD) medicines for serious diseases, including oncology and autoimmune conditions [3]. - The company utilizes its proprietary QuEEN™ discovery engine, which integrates AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to design MGDs with unprecedented selectivity [3]. Research and Development - The recent research highlights the ability of Monte Rosa's QuEEN discovery engine to identify over 100 new protein targets that are amenable to degradation, many of which are currently considered inaccessible to small molecule binding [2]. - The findings significantly broaden the therapeutic reach of Monte Rosa's pipeline, particularly in immunology, inflammation, and oncology, where the company is advancing clinical programs [2]. Strategic Collaborations - Monte Rosa has established a global license agreement with Novartis to develop VAV1-directed molecular glue degraders and a strategic collaboration with Roche to discover MGDs targeting cancer and neurological diseases previously deemed impossible to drug [3].

两年期美债收益率涨9.51个基点，报3.8799%，日内交投于3.7517%-3.9089%区间，本周累涨13.20个基 点。 周四（7月3日）纽约尾盘，美国10年期基准国债收益率上涨6.89个基点，报4.3457%，全天呈现出工字 形走势，整体交投于4.2475%-4.3576%区间，北京时间20:30发布美国非农就业报告时从4.26%一线飙升 至接近4.36%的水平，本周（迄今）累计上涨6.89个基点。 ...